Browse the corpus

REFERENCES American Academy of Pediatrics Committee on Drugs, "Transfer of Drugs and Other Chemicals Into Human Milk," Pediatrics , 2001, 108(3):776-89. [PubMed 11533352 ] Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 97. Basnyat B, Gertsch JH,. Holck PS, et al, “Acetazolamide 125 mg BD is Not Significantly Different from 375 mg BD in the Prevention of Acute Mountain Sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) Trial,” High Alt Med Biol , 2006, 7(1):17-27. [PubMed 16544963 ] Chapron DJ, Gomolin IH, and Sweeney KR, “Acetazolamide Blood Concentrations Are Excessive in the Elderly: Propensity for Acidosis and Relationship to Renal Function,” J Clin Pharmacol , 1989, 29(4):348-53. [PubMed 2498399 ] Chapron DJ, Sweeney KR, Feig PU, et al, “Influence of Advanced Age on the Disposition of Acetazolamide,” Br J Clin Pharmacol , 1985, 19:363-71. [PubMed 3986087 ] Corbett JT, “Acetazolamide and Purpura,” Br Med J , 1985, 1:1122-3. Hackett PH, Roach RC, "High-Altitude Illness," N Engl J Med , 2001, 345(2):107-14. [PubMed 11450659 ] Heller I, Halevy J, Cohen S, et al, “Significant Metabolic Acidosis Induced by Acetazolamide,” Arch Intern Med , 1985, 145(10):1815-7. [PubMed 4037942 ] Luks AM, McIntosh SE, Grissom CK, et al, “Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness,” Wilderness Environ Med , 2010, 21(2):146-55. [PubMed 20591379 ] Marik PE, Kussman BD, Lipman J, et al, "Acetazolamide in the Treatment of Metabolic Alkalosis in Critically Ill Patients," Heart Lung , 1991, 20(5 Pt 1):455-9. [PubMed 1894525 ] Mazur JE, Devlin JW, Peters MJ, et al, "Single Versus Multiple Doses of Acetazolamide for Metabolic Alkalosis in Critically Ill Medical Patients: A Randomized, Double-Blind Trial," Crit Care Med , 1999, 27(7):1257-61. [PubMed 10446816 ] Moviat M, Pickkers P, van der Voort PH, et al, “Acetazolamide-Mediated Decrease in Strong Ion Difference Accounts for the Correction of Metabolic Alkalosis in Critically Ill Patients,” Critical Care , 2006, 10(1):R14. [PubMed 16420662 ] Oles KS, Penry JK, Cole DLW, et al, “Use of Acetazolamide as an Adjunct to Carbamazepine in Refractory Partial Seizures,” Epilepsia , 1989, 30(1):74-8. [PubMed 2492225 ]

Moviat M, Pickkers P, van der Voort PH, et al, “Acetazolamide-Mediated Decrease in Strong Ion Difference Accounts for the Correction of Metabolic Alkalosis in Critically Ill Patients,” Critical Care , 2006, 10(1):R14. [PubMed 16420662 ] Oles KS, Penry JK, Cole DLW, et al, “Use of Acetazolamide as an Adjunct to Carbamazepine in Refractory Partial Seizures,” Epilepsia , 1989, 30(1):74-8. [PubMed 2492225 ] Parikh JR, Nolan RL, Bannerjee A, et al, “Acetazolamide-Associated Nephrocalcinosis in a Transplant Kidney,” Transplantation , 1995, 59(12):1742-3. [PubMed 7604446 ] Piepgras A, Schmiedek P, Leinsinger G, et al, “A Simple Test to Assess Cerebrovascular Reserve Capacity Using Transcranial Doppler Sonography and Acetazolamide,” Stroke , 1990, 21(9):1306-11. [PubMed 2204147 ] Pollard AJ, Niermeyer S, Barry P, et al, “Children at High Altitude: An International Consensus Statement by an Ad Hoc Committee of the International Society for Mountain Medicine, March 12, 2001,” High Alt Med Biol , 2001, 2(3):389-403. [PubMed 11682018 ] Reiss WG and Oles KS, “Acetazolamide in the Treatment of Seizures,” Ann Pharmacother , 1996, 30(5):514-9. [PubMed 8740334 ] Rousseau P and Fuentevilla-Clifton A, “Acetazolamide and Salicylate Interaction in the Elderly: A Case Report,” J Am Geriatr Soc , 1993, 41(8):868-9. [PubMed 8340566 ] Schwenk MH, St. Peter WL, Meese MG, et al, “Acetazolamide Toxicity and Pharmacokinetics in Patients Receiving Hemodialysis,” Pharmacotherapy , 1995, 15(4):522-7. [PubMed 7479208 ] Shinnar S, Gammon K, Bergman EW Jr, et al, “Management of Hydrocephalus in Infancy: Use of Acetazolamide and Furosemide to Avoid Cerebrospinal Fluid Shunts,” J Pediatr , 1985, 107(1):31-7. [PubMed 4009338 ] Söderman P, Hartvig P, and Fagerlund C, "Acetazolamide Excretion Into Human Breast Milk," Br J Clin Pharmacol , 1984, 17(5):599-600. [PubMed 6733009 ] Vaziri ND, Saiki J, Barton CH, et al, “Hemodialyzability of Acetazolamide,” South Med J , 1980, 73(4):422-3. [PubMed 7367929 ] Wagenaar M, Vos P, Heijdra Y, et al, “Comparison of Acetazolamide and Medroxyprogesterone as Respiratory Stimulants in Hypercapnic Patients With COPD,” Chest , 2003, 123(5):1450-9. Wandstrat TL and Phillips J, “Pseudotumor Cerebri Responsive to Acetazolamide,” Ann Pharmacother , 1995, 29(3):318. Weiss IS, “Hirsutism After Chronic Administration of Acetazolamide,” Am J Ophthalmol , 1974, 78(2):327-8. [PubMed 4847470 ] Topic 9268 Version 46.0

Wagenaar M, Vos P, Heijdra Y, et al, “Comparison of Acetazolamide and Medroxyprogesterone as Respiratory Stimulants in Hypercapnic Patients With COPD,” Chest , 2003, 123(5):1450-9. Wandstrat TL and Phillips J, “Pseudotumor Cerebri Responsive to Acetazolamide,” Ann Pharmacother , 1995, 29(3):318. Weiss IS, “Hirsutism After Chronic Administration of Acetazolamide,” Am J Ophthalmol , 1974, 78(2):327-8. [PubMed 4847470 ] Topic 9268 Version 46.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]